Exploring the link between drugs and microbiota: a growing imperative in precision medicine

The intricate interactions between gut microbiota and drugs.

FDA delays decision of Soleno’s Prader-Willi syndrome drug – Pharmaceutical Technology

The extension allows the FDA time to complete its review. Credit: izzuanroslan via Shutterstock. The US Food and Drug Administration (FDA) has delayed its decision

November 27, 2024

AstraZeneca completes Gracell Biotechnologies acquisition

Share this article AstraZeneca will gain access to GC012F, a key asset from Gracell. Credit: rarrarorro / Shutterstock.com. AstraZeneca has concluded its acquisition of China-based

February 23, 2024

Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program | Psychedelic Invest

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and

October 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.